SYNTARA
Who is SYNTARA?
Syntara Limited (ASX:SNT) is a clinical stage drug development company targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. Synta...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
1998 (28 years)
Address:
20 RODBOROUGH RD; FRENCHS FOREST, NSW 2086, AU
Employees by Department
Key Decision Makers
Malcolm Mccomas
Chairman
Kristen Morgan
Head of Medical and Regulatory Affairs
Dieter Hamprecht
Head of Chemistry
Insight
Signals
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
6employees
Non-managers
20employees
Financials
HIGH
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has SYNTARA been operating for?
- What is the funding status of SYNTARA?
- Where is SYNTARA's headquarter?
- What SYNTARA's spending power?
- Does SYNTARA have a presence in the domain it operates in?